Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cariprazine for Prevention of Relapse in Bipolar I Disorder
NCT03573297Phase 3Completed
- Sponsor
- AbbVie Inc.
- Start
- Jun 2018
- Primary completion
- Sep 2022
- Modality
- Orthosteric Ligands
- Countries
- 11
01
Overview
A Phase 3 trial of cariprazine in bipolar I disorder, sponsored by AbbVie Inc.. Started Jun 2018; status: completed.
02
Drugs
cariprazine
03
Conditions
bipolar I disorder
Beyond the preview
Go deeper on NCT03573297.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03573297.